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In the first paragraph in the “Gene Expression Profiling”
section, the third sentence should say, “In particular, cases
with higher levels of NFκB-related molecules or other
evidence of NFκB activation showed better survival, with a
median OS of 25 months (range 0–124 months) versus a
median OS of 12 months (range 0–19 months) (P=0.032)
[36, 38].”
The online version of the original article can be found at doi:10.1007/
s11899-010-0062-x.
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